难治性支原体肺炎应用小剂量糖皮质激素联合普米克吸入治疗的临床研究
|
摘要
目的探讨难治性支原体肺炎应用小剂量糖皮质激素联合普米克吸入治疗的临床疗效。方法选取2014年6月至2015年6月于我院就诊的难治性支原体肺炎患者共86例,按治疗方法的不同将患者分为对照组和观察组,每组各43例。对照组患者采用基础治疗,观察组患者在此基础上采用小剂量糖皮质激素联合普米克吸入治疗。比较两组患者的治疗效果。结果观察组治疗总有效率为97.67%,显著高于对照组的74.42%,差异具有统计学意义(P<0.05)。观察组C-反应蛋白、红细胞沉降率、中性粒细胞等水平均明显低于对照组,差异具有统计学意义(P<0.05)。结论采用小剂量糖皮质激素联合普米克吸入治疗难治性支原体肺炎,可以有效改善患者的治疗效果,值得在临床上大力推广和应用。
Objective To investigate the clinical efficacy of low-dose glucocorticoid combined with pulmicort inhalation therapy in refractory mycoplasma pneumonia. Methods 86 patients with refractory mycoplasma pneumonia treated in our hospital from June 2014 to June 2015 were selected and divided into control group and observation group according to different treatment methods, with 43 cases in each group. The control group was given basic treatment, the observation group was given low-dose glucocorticoid combined with pulmicort inhalation therapy on this basis. The treatment effects of two groups were compared. Results The total effective rate of observation group was 97.67%, significantly higher than 74.42% of control group, with statistically significant difference(P <0.05). The C- reactive protein level, erythrocyte sedimentation rate and neutrophil level of observation group were significantly lower than those of control group, with statistically significant difference(P <0.05). Conclusions Low-dose glucocorticoid combined with pulmicort inhalation therapy in refractory mycoplasma pneumonia can effectively improve the treatment effect, which is worthy of promotion and application in clinic.
Objective To investigate the clinical efficacy of low-dose glucocorticoid combined with pulmicort inhalation therapy in refractory mycoplasma pneumonia. Methods 86 patients with refractory mycoplasma pneumonia treated in our hospital from June 2014 to June 2015 were selected and divided into control group and observation group according to different treatment methods, with 43 cases in each group. The control group was given basic treatment, the observation group was given low-dose glucocorticoid combined with pulmicort inhalation therapy on this basis. The treatment effects of two groups were compared. Results The total effective rate of observation group was 97.67%, significantly higher than 74.42% of control group, with statistically significant difference(P <0.05). The C- reactive protein level, erythrocyte sedimentation rate and neutrophil level of observation group were significantly lower than those of control group, with statistically significant difference(P <0.05). Conclusions Low-dose glucocorticoid combined with pulmicort inhalation therapy in refractory mycoplasma pneumonia can effectively improve the treatment effect, which is worthy of promotion and application in clinic.
引文
[1]甘文波.小剂量糖皮质激素对小儿肺炎支原体肺炎患儿免疫的影响[J].中国当代医药,2013,20(9):40-41.
[2]高大明,翟爱国,刘永红,等.小剂量激素短疗程辅助治疗支原体肺炎临床观察[J].安徽医药,2010,14(6):713-714.
[3]盛瑶.小剂量糖皮质激素短疗程辅助治疗儿童难治性支原体肺炎48例疗效观察[J].中国初级卫生保健,2013,27(1):65-66.
[4]王丹霞.小剂量糖皮质激素在儿童支原体肺炎中应用疗效研究[J].中外医学研究,2011,9(29):30-31.
[5]苏锦友.应用小剂量糖皮质激素辅助治疗儿童支原体肺炎的临床研究[J].中国保健营养(上旬刊),2013,23(8):4519-4520.
[6]熊金国,张荣贵.儿童支原体肺炎短期应用小剂量糖皮质激素的临床研究[J].医学信息(上旬刊),2010,23(4):903-904.
[7]熊金国,张荣贵.儿童支原体肺炎短期应用小剂量糖皮质激素的临床研究[J].医学信息(上旬刊),2010,23(4):903-904.
[8]杨挺.小剂量激素辅助治疗小儿难治性肺炎支原体肺炎的疗效观察[J].中国医刊,2014,49(1):85-87.
[2]高大明,翟爱国,刘永红,等.小剂量激素短疗程辅助治疗支原体肺炎临床观察[J].安徽医药,2010,14(6):713-714.
[3]盛瑶.小剂量糖皮质激素短疗程辅助治疗儿童难治性支原体肺炎48例疗效观察[J].中国初级卫生保健,2013,27(1):65-66.
[4]王丹霞.小剂量糖皮质激素在儿童支原体肺炎中应用疗效研究[J].中外医学研究,2011,9(29):30-31.
[5]苏锦友.应用小剂量糖皮质激素辅助治疗儿童支原体肺炎的临床研究[J].中国保健营养(上旬刊),2013,23(8):4519-4520.
[6]熊金国,张荣贵.儿童支原体肺炎短期应用小剂量糖皮质激素的临床研究[J].医学信息(上旬刊),2010,23(4):903-904.
[7]熊金国,张荣贵.儿童支原体肺炎短期应用小剂量糖皮质激素的临床研究[J].医学信息(上旬刊),2010,23(4):903-904.
[8]杨挺.小剂量激素辅助治疗小儿难治性肺炎支原体肺炎的疗效观察[J].中国医刊,2014,49(1):85-87.